JM9-28359-25401
4 vaccinations
1 coded response
52 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 201 / VA
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
MMH-19664-37423
Child or adolescent in my care · Female · 2022-06-28
NL9-44818-73537
Child or adolescent in my care · Male · 2022-06-28
Timeline
-
2021-03-26
Registered in v-safe
-
2021-03-26
Dose 1 — Moderna
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-16
-
2021-04-23
Dose 2 — Moderna
- 2021-04-23
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-07-24
- 2021-10-22
-
2021-11-19
Dose 3 — Moderna
-
2021-11-19
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-21
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Swelling · Fatigue or tiredness, NauseaAdult check-in
-
2021-11-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-11-23
- 2021-11-24
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2021-12-31
- 2022-02-18
- 2022-05-20
-
2022-10-12
Dose 4 — Pfizer-BioNTech
- 2022-10-12
-
2022-10-13
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-14
- 2022-10-17
- 2022-10-18
- 2022-10-21
- 2022-10-26
- 2022-11-03
- 2022-11-11
- 2022-11-16
-
2022-11-23
Survey response — day 42, dose 4MedDRA: Costochondritis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: CostochondritisMedDRA releases: 2024-11 · check-in free text available
-
2022-11-23
Report sent to call center — day 42, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-11-25
- 2023-01-11
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Moderna | |
| 2 | 2021-04-23 | Moderna | |
| 3 | 2021-11-19 | Moderna | No |
| 4 | 2022-10-12 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — day 42, dose 4
Symptoms: Costochondritis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Costochondritis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release